Your browser doesn't support javascript.
loading
A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity.
Roex, Marthe C J; Hageman, Lois; Veld, Sabrina A J; van Egmond, Esther; Hoogstraten, Conny; Stemberger, Christian; Germeroth, Lothar; Einsele, Hermann; Falkenburg, J H Frederik; Jedema, Inge.
Afiliação
  • Roex MCJ; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Hageman L; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Veld SAJ; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Egmond E; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Hoogstraten C; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Stemberger C; Juno Therapeutics GmbH, a Celgene Company, Munich, Germany; and.
  • Germeroth L; Juno Therapeutics GmbH, a Celgene Company, Munich, Germany; and.
  • Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Falkenburg JHF; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Jedema I; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
Blood ; 136(4): 455-467, 2020 07 23.
Article em En | MEDLINE | ID: mdl-32483595
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Antígeno HLA-A2 / Antígenos de Histocompatibilidade Menor / Apresentação de Antígeno / Vacinas Anticâncer / Antígenos de Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Citotóxicos / Antígeno HLA-A2 / Antígenos de Histocompatibilidade Menor / Apresentação de Antígeno / Vacinas Anticâncer / Antígenos de Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda